CompanyDrug

CDE Lists Five Drugs and One Companion Diagnostic for Priority Review Status

CompanyMedical Device

Hainan Province Approves Heart-Lung Walking Test Analysis Software as Category II Device

CompanyDrug

Frontera Therapeutics Receives FDA Approval for Phase II Study of First Chinese rAAV Gene Therapy

CompanyDeals

Longbio Pharma Secures RMB 100 Million in Series B2 Financing to Advance Clinical Programs

Policy / Regulatory

Yunnan Province Increases Pediatric Medical Service Prices for Children Under 6

Company

Sihuan Pharmaceutical Sees Aesthetics and Biopharma Growth Amid Overall Revenue Dip

R&D

Global Researchers Call for the Revival of the Human Genome Project to Advance Precision Medicine

CompanyDrug

Sanofi’s Sarclisa Secures FDA Approval for First-Line Multiple Myeloma Treatment

CompanyDrug

Novo Nordisk’s Obesity Drug Monlunabant Phase IIa Results Lead to Share Price Drop

CompanyDeals

Janssen and Yuhan Halt Development of Next-Gen EGFR Inhibitor for NSCLC

CompanyDrug

Sichuan Biokin’s Multi-Specific Antibody GNC-077 Gets NMPA Nod for Advanced Solid Tumor Clinical Trial

CompanyDrug

SciClone Pharmaceuticals Gets NMPA Approval for Phase III Study of First-in-Class SERD Orserdu